CytoSorbents Corp. (CTSO)
0.3356
0.00 (0.00%)
USD |
NASDAQ |
Aug 28, 16:00
0.341
+0.01
(+1.61%)
After-Hours: 20:00
CytoSorbents Cash from Operations (Quarterly) : -0.583M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.583M |
| March 31, 2026 | -1.162M |
| December 31, 2025 | -4.825M |
| September 30, 2025 | -2.577M |
| June 30, 2025 | -1.51M |
| March 31, 2025 | -3.465M |
| December 31, 2024 | -2.342M |
| September 30, 2024 | -2.463M |
| June 30, 2024 | -4.794M |
| March 31, 2024 | -4.830M |
| December 31, 2023 | -6.407M |
| September 30, 2023 | -5.206M |
| June 30, 2023 | -6.933M |
| March 31, 2023 | -3.108M |
| December 31, 2022 | -5.340M |
| September 30, 2022 | -6.735M |
| June 30, 2022 | -8.04M |
| March 31, 2022 | -8.119M |
| December 31, 2021 | -5.492M |
| September 30, 2021 | -4.134M |
| June 30, 2021 | -2.036M |
| March 31, 2021 | -2.344M |
| December 31, 2020 | -1.058M |
| September 30, 2020 | -3.284M |
| June 30, 2020 | 1.938M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.209M |
| December 31, 2019 | -4.124M |
| September 30, 2019 | -5.208M |
| June 30, 2019 | -3.189M |
| March 31, 2019 | -4.238M |
| December 31, 2018 | -2.707M |
| September 30, 2018 | -2.636M |
| June 30, 2018 | -3.293M |
| March 31, 2018 | -2.204M |
| December 31, 2017 | -0.4095M |
| September 30, 2017 | -2.183M |
| June 30, 2017 | -1.883M |
| March 31, 2017 | -1.984M |
| December 31, 2016 | -1.079M |
| September 30, 2016 | -2.468M |
| June 30, 2016 | -1.922M |
| March 31, 2016 | -1.261M |
| December 31, 2015 | -2.187M |
| September 30, 2015 | -2.263M |
| June 30, 2015 | -2.15M |
| March 31, 2015 | -2.409M |
| December 31, 2014 | -2.472M |
| September 30, 2014 | -1.928M |
| June 30, 2014 | -1.461M |
| March 31, 2014 | -0.8001M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Abbott Laboratories | 2.488B |
| AngioDynamics, Inc. | 17.45M |
| Alphatec Holdings, Inc. | 20.51M |
| AtriCure, Inc. | 22.19M |
| Baxter International, Inc. | 285.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.007M |
| Free Cash Flow | -9.583M |
| Free Cash Flow Per Share (Quarterly) | -0.0101 |
| Free Cash Flow to Equity (Quarterly) | -1.075M |
| Free Cash Flow to Firm (Quarterly) | 0.233M |
| Free Cash Flow Yield | -45.49% |